Kaposi's sarcoma-associated herpesvirus LANA-1 interacts with the short variant of BRD4 and releases cells from a BRD4- and BRD2/RING3-induced G1 cell cycle arrest

J Virol. 2006 Nov;80(21):10772-86. doi: 10.1128/JVI.00804-06. Epub 2006 Aug 23.

Abstract

The Kaposi's sarcoma-associated herpesvirus (KSHV) latency-associated nuclear antigen 1 (LANA-1) is required for the replication of episomal viral genomes. Regions in its N-terminal and C-terminal domains mediate the interaction with host cell chromatin. Several cellular nuclear proteins, e.g., BRD2/RING3, histones H2A and H2B, MeCP2, DEK, and HP1alpha, have been suggested to mediate this interaction. In this work, we identify the double-bromodomain proteins BRD4 and BRD3/ORFX as additional LANA-1 interaction partners. The carboxy-terminal region of the short variant of BRD4 (BRD4S) containing the highly conserved extraterminal domain directly interacts with an element in the LANA-1 carboxy-terminal domain. We show that ectopically expressed BRD4S and BRD2/RING3 delay progression into the S phase of the cell cycle in epithelial and B-cell lines and increase cyclin E promoter activity. LANA-1 partly releases epithelial and B cells from a BRD4S- and BRD2/RING3-induced G1 cell cycle arrest and also promotes S-phase entry in the presence of BRD4S and BRD2/RING3. This is accompanied by a reduction in BRD4S-mediated cyclin E promoter activity. Our data are in keeping with the notion that the direct interaction of KSHV LANA-1 with BRD4 and other BRD proteins could play a role in the G1/S phase-promoting functions of KSHV LANA-1. Further, our data support a model in which the LANA-1 C terminus contributes to a functional attachment to acetylated histones H3 and H4 via BRD4 and BRD2, in addition to the recently demonstrated direct interaction (A. J. Barbera, J. V. Chodaparambil, B. Kelley-Clarke, V. Joukov, J. C. Walter, K. Luger, and K. M. Kaye, Science 311:856-861, 2006) of the LANA-1 N terminus with histones H2A and H2B.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, Viral / chemistry
  • Antigens, Viral / genetics
  • Antigens, Viral / immunology
  • Antigens, Viral / physiology*
  • Baculoviridae / genetics
  • Base Sequence
  • Binding Sites
  • Cell Cycle Proteins
  • Cell Line
  • Chromobox Protein Homolog 5
  • Cyclin E / genetics
  • DNA Primers / genetics
  • G1 Phase / physiology*
  • Genetic Variation
  • HeLa Cells
  • Herpesvirus 8, Human / genetics
  • Herpesvirus 8, Human / immunology
  • Herpesvirus 8, Human / pathogenicity*
  • Herpesvirus 8, Human / physiology
  • Humans
  • Nuclear Proteins / chemistry
  • Nuclear Proteins / genetics
  • Nuclear Proteins / immunology
  • Nuclear Proteins / physiology*
  • Oncogene Proteins, Fusion / chemistry
  • Oncogene Proteins, Fusion / genetics
  • Oncogene Proteins, Fusion / physiology*
  • Promoter Regions, Genetic
  • Protein Serine-Threonine Kinases / physiology*
  • Protein Structure, Tertiary
  • Recombinant Proteins / chemistry
  • Recombinant Proteins / genetics
  • Recombinant Proteins / metabolism
  • S Phase / physiology
  • Transcription Factors
  • Transcriptional Activation

Substances

  • Antigens, Viral
  • BRD2 protein, human
  • BRD4 protein, human
  • CBX5 protein, human
  • Cell Cycle Proteins
  • Cyclin E
  • DNA Primers
  • Nuclear Proteins
  • Oncogene Proteins, Fusion
  • Recombinant Proteins
  • Transcription Factors
  • latency-associated nuclear antigen
  • Chromobox Protein Homolog 5
  • Protein Serine-Threonine Kinases